XJIPC OpenIR  > 多语种信息技术研究室
PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction
You, ZH (You, Zhu-Hong); Huang, ZA (Huang, Zhi-An); Zhu, ZX (Zhu, Zexuan); Yan, GY (Yan, Gui-Ying); Li, ZW (Li, Zheng-Wei); Wen, ZK (Wen, Zhenkun); Chen, X (Chen, Xing)
2017
发表期刊PLOS COMPUTATIONAL BIOLOGY
卷号13期号:3
摘要In the recent few years, an increasing number of studies have shown that microRNAs (miRNAs) play critical roles in many fundamental and important biological processes. As one of pathogenetic factors, the molecular mechanisms underlying human complex diseases still have not been completely understood from the perspective of miRNA. Predicting potential miRNA-disease associations makes important contributions to understanding the pathogenesis of diseases, developing new drugs, and formulating individualized diagnosis and treatment for diverse human complex diseases. Instead of only depending on expensive and time-consuming biological experiments, computational prediction models are effective by predicting potential miRNA-disease associations, prioritizing candidate miRNAs for the investigated diseases, and selecting those miRNAs with higher association probabilities for further experimental validation. In this study, Path-Based MiRNA-Disease Association (PBMDA) prediction model was proposed by integrating known human miRNA-disease associations, miRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity for miRNAs and diseases. This model constructed a heterogeneous graph consisting of three interlinked sub-graphs and further adopted depth-first search algorithm to infer potential miRNA-disease associations. As a result, PBMDA achieved reliable performance in the frameworks of both local and global LOOCV (AUCs of 0.8341 and 0.9169, respectively) and 5-fold cross validation (average AUC of 0.9172). In the cases studies of three important human diseases, 88% (Esophageal Neoplasms), 88% (Kidney Neoplasms) and 90% (Colon Neoplasms) of top-50 predicted miRNAs have been manually confirmed by previous experimental reports from literatures. Through the comparison performance between PBMDA and other previous models in case studies, the reliable performance also demonstrates that PBMDA could serve as a powerful computational tool to accelerate the identification of disease-miRNA associations.
DOI10.1371/journal.pcbi.1005455
WOS记录号WOS:000398031900018
引用统计
被引频次:46[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.xjipc.cas.cn/handle/365002/4787
专题多语种信息技术研究室
作者单位1.Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Urumqi, Peoples R China
2.Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Peoples R China
3.Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China
4.China Univ Min & Technol, Sch Comp Sci & Technol, Xuzhou, Peoples R China
5.China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou, Peoples R China
推荐引用方式
GB/T 7714
You, ZH ,Huang, ZA ,Zhu, ZX ,et al. PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction[J]. PLOS COMPUTATIONAL BIOLOGY,2017,13(3).
APA You, ZH .,Huang, ZA .,Zhu, ZX .,Yan, GY .,Li, ZW .,...&Chen, X .(2017).PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction.PLOS COMPUTATIONAL BIOLOGY,13(3).
MLA You, ZH ,et al."PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction".PLOS COMPUTATIONAL BIOLOGY 13.3(2017).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
PBMDA A novel and ef(1676KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[You, ZH (You, Zhu-Hong)]的文章
[Huang, ZA (Huang, Zhi-An)]的文章
[Zhu, ZX (Zhu, Zexuan)]的文章
百度学术
百度学术中相似的文章
[You, ZH (You, Zhu-Hong)]的文章
[Huang, ZA (Huang, Zhi-An)]的文章
[Zhu, ZX (Zhu, Zexuan)]的文章
必应学术
必应学术中相似的文章
[You, ZH (You, Zhu-Hong)]的文章
[Huang, ZA (Huang, Zhi-An)]的文章
[Zhu, ZX (Zhu, Zexuan)]的文章
相关权益政策
暂无数据
收藏/分享
文件名: PBMDA A novel and effective path-based computational model for miRNA-disease association prediction.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。